Hepatitis B seroprevalence among HIV-positive adults in the Free State, South Africa
Open Access
- 1 January 2025
- journal article
- Published by AOSIS in Southern African Journal of HIV Medicine
- Vol. 26 (1) , 8
Abstract
Background: HIV and hepatitis B virus (HBV) coinfection impacts negatively on the prognosis for people living with HIV (PLHIV). HBV is relatively neglected compared to HIV in the South African setting, with limited coinfection seroprevalence data from the Free State. Objectives: This study aimed to determine the seroprevalence of current and previous HBV in PLHIV in the Free State, South Africa. Method: In this descriptive cross-sectional study, 1007 residual HIV viral load (VL) samples were selected and screened for markers of current HBV infection (hepatitis B surface antigen [HBsAg]) and previous exposure to HBV (total antibodies to hepatitis B core antigen [HBcTA]) between 01 February 2022 and 31 March 2022. Seroprevalence was assessed for municipal health districts, age, sex, and HIV VL categories. Results: HBsAg seroprevalence was 6.26% and HBcTA seroprevalence was 36.05%. HBsAg seroprevalence was significantly higher in men at 8.12% as compared to women at 4.38% (P = 0.014). HBcTA seropositivity was also higher in men than in women, at 42.97% for men and 29.08% for women (P < 0.0001). Peak HBsAg and HBcTA positivity was observed among the 40–59-year age group in both men and women. No significant difference was found in HBV seroprevalence and exposure between districts or HIV VL categories. Conclusion: These findings demonstrate that PLHIV in the Free State, South Africa, fall under the intermediate HBV prevalence category. HBV infection remains a public health concern and emphasis should be placed on identifying and addressing programmatic gaps regarding diagnosis and management.Keywords
This publication has 39 references indexed in Scilit:
- Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in Sub-Saharan AfricaJournal of Clinical Virology, 2014
- Hepatitis B virus in HIV-infected patients in north-eastern South Africa: Prevalence, exposure, protection and response to HAARTSouth African Medical Journal, 2013
- The role of HBsAg quantification for monitoring natural history and treatment outcomeLiver International, 2013
- Hepatitis B Virus Infection in Human Immunodeficiency Virus Infected Southern African Adults: Occult or Overt – That Is the QuestionPLOS ONE, 2012
- Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicityVaccine, 2012
- HBV/HIV co-infection: The dynamics of HBV in South African patients with AIDSSouth African Medical Journal, 2012
- Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infectionInternational Journal of Infectious Diseases, 2012
- The prevalence of hepatitis B infection in a rural South African HIV clinic.2011
- Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen.2009
- Hepatitis B virus and human immunodeficiency virus co‐infection in sub‐Saharan Africa: a call for further investigationLiver International, 2005